DIAZEPAM INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2D226F3517 to DMS Pharmaceutical Group Inc on September 15, 2026, for the procurement of Diazepam Injection. This specific order, valued at 185.48 dollars for one package, is issued under the broader delivery order SPE2DX25D9822. The item is identified by National Stock Number 6505015053476 and is designated for delivery to the USNS Lansing under FOB destination terms. This task order is part of a larger medical supply chain agreement managed by DLA Troop Support, which originally awarded a 20 million dollar contract to DMS Pharmaceutical Group Inc on March 7, 2025, under solicitation SPE2DX-24-R-0001. The current order ensures the delivery of critical pharmaceutical supplies as specified by the Department of Defense.
General Info
Contract Value
$185.48Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
